Projects
PENBRAYA (Meningococcal A, B, C, W, and Y vaccine) for the Prevention of Meningococcal Disease, USA
PENBRAYA™, a meningococcal A, B, C, W, and Y vaccine, is indicated for active immunisation to prevent invasive disease caused …
Ruzurgi (amifampridine) for the Treatment of LEMS
Ruzurgi® (amifampridine) is indicated for the treatment of adults and children aged six years and above with Lambert-Eaton myasthenic syndrome …
Rituxan for the Treatment of Non-Hodgkin’s Lymphoma, US
Rituxan (rituximab) is a prescription medicine indicated to treat blood cancers, autoimmune diseases and inflammatory conditions, including follicular lymphoma (FL), …
Repatha for the Treatment of Heterozygous and Homozygous Familial Hypercholesterolaemia, US
Repatha (evolocumab) is a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) for lowering cholesterol in patients. It …
REBLOZYL for the Treatment of Anaemia Associated with Beta-Thalassemia, US
REBLOZYL (luspatercept-aamt) is a novel erythroid maturation agent (EMA) approved to treat anaemia associated with beta-thalassemia in adult patients who require …
Rezdiffra for the Treatment of Noncirrhotic Non-alcoholic Steatohepatitis, US
Rezdiffra (resmetirom) is a novel therapeutic indicated alongside diet and exercise for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis …
HYQVIA for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy, USA
HYQVIA® (immune globulin infusion 10%) is a liquid medicine that combines immune globulin infusion at a 10% concentration with the …
Vabysmo (faricimab-svoa) for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema
Vabysmo™ (faricimab-svoa) is a bispecific antibody indicated for the treatment of adult patients with neovascular (wet) age-related macular degeneration (nAMD), …
Phesgo for the Treatment of HER2-Positive Breast Cancer, US
Phesgo is a fixed-dose combination (FDC) of Perjeta and Herceptin with hyaluronidase for the treatment of human epidermal growth factor …
Sativex (Nabiximols) for the Treatment of Multiple Sclerosis, Europe
Sativex®, also known as Nabiximols, is an oromucosal spray comprising two chemical extracts - active cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) …
Veopoz for the Treatment of Chaple Disease, US
Veopoz (pozelimab) is a complement inhibitor indicated for the treatment of adult and paediatric patients aged one and older with …
Stelara for the Treatment of Moderate to Severe Crohn’s Disease, US
Developed by Janssen Biotech, Stelara is a biologic therapy indicated for the treatment of multiple indications, including moderate to severely …
NGENLA (somatrogon) for the Treatment of Paediatric Growth Hormone Deficiency, USA
NGENLA® (somatrogon) is a once-weekly, long-acting therapy created using recombinant technology for paediatric patients aged three years and older, who …
SPINRAZA for the Treatment of Spinal Muscular Atrophy, US
SPINRAZA is the first approved treatment for spinal muscular atrophy (SMA) in paediatric and adult patients. It was originally developed by …
TALVEY for the Treatment of Multiple Myeloma, US
TALVEY is indicated as a monotherapy for adults with relapsed or refractory multiple myeloma (RRMM) who have received at least …